ClinicalTrialsFinder
RecruitingPhase 4NCT06951802

Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine

Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine A Single-Centre, Prospective, Randomized, Controlled Trial

Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

118 participants

Start Date

Dec 3, 2024

Study Type

INTERVENTIONAL

Conditions

Endometriosis

Summary

RCT comparing intraoperative administration of low-dose ketamine during laparoscopic endometriosis operation and the postoperative pain outcome

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ketamine and a drug called Propofol for people with endometriosis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

Low-dose administration of ketamine during laparoscopic surgery

DRUGPropofol

Control group

Locations(1)

Inselspital Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06951802

Related Trials

Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis

NCT064774061 location

Pelvic Pain Electro-Acupuncture

NCT073050251 location

Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO)

NCT074690071 location

Biomarkers for Endometriosis

NCT077137971 location

Pelvic Floor Muscle Function and Endometriosis-Related Pelvic Pain

NCT077131081 location